Interdisciplinary E-health Based Follow-up of Preterm Born Children
NCT ID: NCT06345664
Last Updated: 2025-03-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
90 participants
INTERVENTIONAL
2023-03-01
2025-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
E-health-supported Diagnostic and Intervention in Preterm Born Children and Their Families
NCT06939192
Developmental Outcomes of Extreme Prematurity, 5-15 Years Postpartum
NCT01430832
Longitudinal Study of Music Therapy's Effectiveness for Premature Infants and Their Caregivers
NCT03564184
Transition to Home (TtH) After Preterm Birth
NCT03460496
The Use of an Age-linked App for Parents During and After a NICU Stay
NCT03232190
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* T0: App-questions for the children at the ages of 5 and 10 and the parents of all children to mental, somatic and sleep problems of the children and well-being of the parents, sleep tracking and recording of a sleep sequence of the children; differentiated examinations and questionnaires to mental and somatic problems of the children by interdisciplinary study team
* Interdisciplinary study team meeting to generate recommendations for the families
* Interdisciplinary study team recommendations for the families
* T1: Comparable to T0 but only measurements that were assessed with questionnaires/at home plus post-experimental questionnaire
* Focus groups with participating families and the study team experts for evaluation of the study procedure and intervention
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diagnostic assessments and intervention
All families get a diagnostics and intervention recommendations.
Diagnostics and intervention recommendations
All families get the same diagnostics and receive individual treatment recommendations.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diagnostics and intervention recommendations
All families get the same diagnostics and receive individual treatment recommendations.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Existence of systematical neonatal data and consent of the care person to use this data
* Existence of the data of the 2 year regular follow-up (for the 5 and 10 year olds)
Exclusion Criteria
* insufficient knowledge of the German language of both parents
2 Years
10 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Tuebingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
PD Dr. Annette Conzelmann
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Annette Conzelmann, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
University Hospital Tuebingen
Axel Franz, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
University Hospital Tuebingen
Mirja Quante, Dr.
Role: PRINCIPAL_INVESTIGATOR
University Hospital Tuebingen
Ándrea Bevot, Dr.
Role: PRINCIPAL_INVESTIGATOR
University Hospital Tuebingen
Tobias Renner, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
University Hospital Tuebingen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Tuebingen
Tübingen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Annette Conzelmann, Prof. Dr.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
548/2022BO1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.